Filing Details
- Accession Number:
- 0001209191-18-051667
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-09-19 17:25:30
- Reporting Period:
- 2018-09-17
- Accepted Time:
- 2018-09-19 17:25:30
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1524472 | Xylem Inc. | XYL | Pumps & Pumping Equipment (3561) | 452080495 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1531414 | R Colin Sabol | 1 International Drive C/O Xylem Inc. Rye Brook NY 10573 | Senior Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2018-09-17 | 7,017 | $38.76 | 41,988 | No | 4 | M | Direct | |
Common Stock | Disposition | 2018-09-17 | 7,017 | $81.37 | 34,971 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2018-09-17 | 4,000 | $35.96 | 38,971 | No | 4 | M | Direct | |
Common Stock | Disposition | 2018-09-17 | 4,000 | $81.37 | 34,971 | No | 4 | S | Direct | |
Common Stock | Disposition | 2018-09-17 | 3,644 | $81.37 | 31,327 | No | 4 | S | Direct | |
Common Stock | Disposition | 2018-09-17 | 2,500 | $81.37 | 28,827 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2018-09-17 | 7,017 | $0.00 | 7,017 | $38.76 |
Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2018-09-17 | 4,000 | $0.00 | 4,000 | $35.96 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2024-02-25 | No | 4 | M | Direct | |
15,930 | 2025-02-25 | No | 4 | M | Direct |
Footnotes
- The exercise and sale were made pursuant to a 10b5-1 plan adopted by the reporting person on August 17, 2018.
- This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"), of sales that were executed at prices ranging from $80.85 to $81.63 per Share. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.
- This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"), of sales that were executed at prices ranging from $80.87 to $81.64 per Share. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.
- The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on August 17, 2018
- This price represents the weighted average price per Share of the Issuer, of sales that were executed at prices ranging from $80.84 to $81.60 per Share. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price
- This price represents the weighted average price per Share of the Issuer, of sales that were executed at prices ranging from $80.91 to $81.64 per Share. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price
- These options are fully vested and exercisable.